Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution

DRUG2 trials

Sponsors

Alcon Research, Mayo Clinic

Conditions

Ocular HypertensionOpen Angle Glaucoma

Phase 3

Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

Active, not recruitingNCT07082816

Alcon ResearchOcular Hypertension, Open Angle Glaucoma

Start: 2025-09-02End: 2026-05-31Updated: 2026-01-13

Phase 4

24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients

RecruitingNCT07325240

Mayo ClinicOcular Hypertension, Open Angle Glaucoma

Start: 2025-11-21End: 2027-10-01Target: 30Updated: 2026-03-23